Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2008 | 64 | 04B |
Tytuł artykułu

Receptory aktywowane przez proliferatory peroksysomow i ich rola w rozrodzie

Warianty tytułu
Peroxisome proliferator activated receptors and their role in reproduction
Języki publikacji
Peroxisome proliferator activated receptors (PPARs) are transcriptional factors belonging to the nuclear receptor superfamily. Three members of the PPAR family have been characterized as PPARα, PPARβ and PPARγ, encoded by separate genes. These isoforms exhibit diverse expression patterns and are activated by different ligands that cause various biological effects. The PPARs are mainly responsible for homeostasis and lipid metabolism. Recently it has been discovered that PPARs play a crucial role in the female reproductive system. PPARγ is expressed in the ovary, endometrium, placenta and fetal membranes. The lack of functional receptors PPARγ or PPARβ results in aberrant placentation and leads to lethality in rodents. PPARβ is abundantly expressed at implantation sites in mice uteri which suggests its role in implantation. Summarizing, in the recent decade studies have revealed new functions of PPARs as the family of receptors that regulate reproductive processes.
Opis fizyczny
  • Instytut Rozrodu Zwierzat i Badan Zywnosci PAN, ul.Tuwima 10, 10-747 Olsztyn
  • 1. Asami-Miyagishi R., Iseki S., Usui M., Uchida K., Kubo H., Morita I.: Expression and function of PPAR gamma in rat placental development. Biochem. Biophys. Res Commun. 2004, 315, 497-501.
  • 2. Auwerx J.: PPARγ, the ultimate thrifty gene. Diabetologia 1999, 42, 1033-1049.
  • 3. Barak Y., Liao D., He W., Ong E. S., Nelson M. C., Olefsky J. M., Boland R., Evans R. M.: Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. USA 2002, 99, 303-308.
  • 4. Barak Y., Nelson M. C., Ong E. S., Jones Y. Z., Ruiz-Lozano P., Chien K. R., Koder A., Evans R. M.: PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell. 1999, 4, 585-595.
  • 5. Berger J., Moller D. E.: The mechanisms of action of PPARs. Ann. Rev. Med. 2002, 53, 409-435.
  • 6. Bogacka I., Ukropcova B., McNeil M., Gimble J. M., Smith S. R.: Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro. J. Clin. Endocrinol. Metab. 2005, 90, 6650-6656.
  • 7. Bogacka I., Xie H., Bray G. A., Smith S. R.: Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 2005, 54, 1392-1399.
  • 8. Bogacka I., Xie H., Bray G. A., Smith S. R.: The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. Diabetes Care 2004, 27, 1660-1667.
  • 9. Braissant O., Foufelle F., Scotto C., Dauca M., Wahli W.: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996, 137, 354-366.
  • 10. Chih-Hao L., Olson P., Evans R. M.: Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors. Endocrinology 2003, 144, 2201-2207.
  • 11. Cui Y., Miyoshi K., Claudio E., Siebenlist U. K., Gonzalez F. J., Flaws J., Wagner K. U., Hennighausen L.: Loss of the peroxisome proliferation-activated receptor gamma (PPAR-gamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J. Biol. Chem. 2002, 277, 17830-17835.
  • 12. Daoud G., Simoneau L., Masse A., Rassart E., Lafond J.: Expression of cFABP and PPAR in trophoblast cells: effect of PPAR ligands on linoleic acid uptake and differentiation. Biochim. Biophys. Acta 2005, 1687, 181-194.
  • 13. Direnzo J., Soderstrom M., Kurokawa R., Ogliastro M., Ricote M., Ingrey S., Horlein A., Rosenfeld M. G., Glass C. K.: Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol. Cell. Biol. 1997, 17, 2166-2176.
  • 14. Dunn-Albanese L. R., Ackerman W. E. 4th, Xie Y., Iams J. D., Kniss D. A.: Reciprocal expression of peroxisome proliferator-activated receptor-gamma and cyclooxygenase-2 in human term parturition. Am. J. Obstet. Gynecol. 2004, 190, 809-816.
  • 15. Evans R. M.: PPARs and the complex journey to obesity. Keio J. Med. 2004, 53, 53-58.
  • 16. Fan W., Yanase T., Morinaga H., Mu Y. M., Nomura M., Okabe T., Goto K., Harada N., Nawata H.: Activation of peroxisome proliferator-activated receptor-gamma and retinoid X receptor inhibits aromatase transcription via nuclear factor-kappaB. Endocrinology 2005, 146, 85-92.
  • 17. Fournier T., Handschuh K., Tsatsaris V., Evain-Brion D.: Involvment of PPARγ in human trophoblast invasion. Placenta 2007, 21, 76-81.
  • 18.Froment P., Fabre S., Dupont J., Pisselet C., Chesneau D., Staels B., Monget P.: Expression and functional role of peroxisome proliferator-activated receptor-gamma in ovarian folliculogenesis in the sheep. Biol. Reprod. 2003, 69, 1665-1674.
  • 19. Gasic S., Bodenburg Y., Nagamani M., Green A., Urban R. J.: Troglitazone inhibits progesterone production in porcine granulosa cells. Endocrinology 1998, 139, 4962-4966.
  • 20. Hu E., Kim J. B., Sarraf P., Spiegelman B. M.: Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR-gamma. Science 1996, 274, 2100-2103.
  • 21. Issemann I., Green S.: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990, 347, 645-649.
  • 22. Kliewer S. A., Sundseth S. S., Jones S. A., Brown P. J., Wisley G. B., Koble C. S., Devchand P., Wahli W., Willson T. M., Lenhard J. M., Lehmann J. M.: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors a and g. Proc. Natl. Acad. Sci. 1997, 94, 4318-4323.
  • 23. Komar C. M., Braissant O., Wahli W., Curry T. E. Jr.: Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology 2001, 142, 4831-4838.
  • 24. Komar C. M.: Peroxisome proliferator-activated receptors (PPARs) and ovarian function - implications for regulating steroidogenesis, differentiation, and tissue remodeling. Reprod. Biol. Endocrinol. 2005, 3, 1-14.
  • 25. Kota B. P., Huang T. H., Roufogalis B. D.: An overview on biological mechanisms of PPARs Pharmacol. Res. 2005, 51, 85-94.
  • 26. Lambe K. G., Tugwood J. D.: A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur. J. Biochem. 1996, 239, 1-7.
  • 27. Lappas M., Permezel M., Georgiou H. M., Rice G. E.: Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone. J. Clin. Endocrinol. Metab. 2002, 87, 4667-4672.
  • 28. Lebovic D. I., Kir M., Casey C. L.: Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. Fertil. Steril. 2004, 82, 1008-1013.
  • 29. Lee S. S., Pineau T., Drago J., Lee E. J., Owens J. W., Kroetz D. L., Fernandez-Salguero P. M., Westphal H., Gonzalez F. J.: Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 1995, 15, 3012-3022.
  • 30. Lehman J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Wilson T. M., Kliewer S. A.: An antidiabetic thiazolidinedione is a high affinity ligand for peroxysome proliferator-activated receptor g. J. Biol. Chem. 1995, 270, 12953-12956.
  • 31. Lehrke M., Lazar M. A.: The many faces of PPAR-gamma. Cell 2005, 123, 993-999.
  • 32. Lim H., Gupta R. A., Ma W. G., Paria B. C., Moller D. E., Morrow J. D., DuBois R. N., Trzaskos J. M., Dey S. K.: Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPAR-delta. Genes. Dev. 1999, 13, 1561-1574.
  • 33. Lohrke B., Viergutz T., Shahi S. K., Pohland R., Wollenhaupt K., Goldammer T., Walzel H., Kanitz W.: Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells. J. Endocrinol. 1998, 159, 429-439.
  • 34. Mangelsdorf D. J., Evans R. M.: The RXR heterodimers and orphan receptors. Cell 1995, 83, 841-850.
  • 35. Marvin K. W., Eykholt R. L., Keelan J. A., Sato T. A., Mitchell M. D.: The 15-deoxy-delta(12,14)-prostaglandin J(2)receptor, peroxisome proliferator activated receptor-gamma (PPAR-gamma) is expressed in human gestational tissues and is functionally active in JEG3 choriocarcinoma cells. Placenta 2000, 21, 436-440.
  • 36. Matsuura H., Adachi H., Smart R. C., Xu X., Arata J., Jetten A. M.: Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells. Mol. Cell. Endocrinol. 1999, 147, 85-92.
  • 37. Nadra K., Anghel S. I., Joye E., Tan N. S., Basu-Modak S., Trono D., Wahli W., Desvergne B.: Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta. Mol. Cell. Biol. 2006, 26, 3266-3281.
  • 38. Palmer C. N., Hsu M. H., Griffin K. J., Raucy J. L., Johnson E. F.: Peroxisome proliferator activated receptor-alpha expression in human liver. Mol. Pharmacol. 1998, 53, 14-22.
  • 39. Peters S. J., Harris R. A., Wu P., Pehleman T. L., Heigenhauser G. J., Spriet L. L.: Human skeletal muscle PDH kinase activity and isoform expression during a 3-day high-fat/low-carbohydrate diet. Am. J. Physiol. Endocrinol. Metab. 2001, 281, 1151-1158.
  • 40. Pineda Torra I., Gervois P., Staels B.: Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr. Opin. Lipidol. 1999, 10, 151-159.
  • 41. Plutzky J.: Emerging concepts in metabolic abnormalities associated with coronary artery disease. Curr. Opin. Cardiol. 2000, 15, 416-421.
  • 42. Saluja I., Granneman J. G., Skoff R. S.: PPARS agonists stimulate oligodendrocyte differentiation in tissue culture. Glia. 2001, 33, 194-204.
  • 43. Schmidt A., Endo N., Rutledge S. J., Vogel R., Shinar D., Rodan G. A.: Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acid. Mol. Endocrinol. 1992, 6, 1634-1641.
  • 44. Schoppee P. D., Garmey J. C., Veldhuis J. D.: Putative Activation of the Peroxisome Proliferator-Activated Receptor ã Impairs Androgen and Enhances Progesterone Biosynthesis in Primary Cultures of Porcine Theca Cells. Biol. Reprod. 2002, 66, 190-198.
  • 45. Smith S. A., Monteh G. R., Robinson J. A., Venkata N. G., May F. J., Roberts-Thomson S. J.: Effect of the peroxisome proliferator-activated receptor beta activator GW0742 in rat cultured cerebellar granule neurons. J. Neurosci. Res. 2004, 77, 240-249.
  • 46. Wang Y. X., Zhang C. L., Yu R. T., Cho H. K., Nelson M. C., Bayuga-Ocampo C. R., Ham J., Kang H., Evans R. M.: Regulation of muscle fiber type and running endurance by PPAR delta. PLOS Biol. 2004, 2, 1532-1539.
  • 47. Zhu Y., Qi C., Korenberg J. R., Chen X. N., Noya D., Rao M. S., Reddy J. K.: Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc. Natl. Acad. Sci. USA 1995, 92, 7921-7925.
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.